Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R S Benjamin

Showing results (81-90 of 258) with videos related to

Pageof 26
Sort By:
Clinical Oncology|June 1, 1979
Regression of regionally advanced melanoma after arterial infusion with cis-platinum and actinomycin-DJ D Pritchard, G M Mavligit, S Wallace, et al.
Cancer|November 1, 1976
A comparison of cyclophosphamide, vincristine, and prednisone (COP) with nitrogen mustard, vincristine, procarbazine, and prednisone (MOPP) in the treatment of nodular, poorly differentiated, lymphocytic lymphomaR S Benjamin, P H Wiernik, M J O'Connell, et al.
Oncology Reports|June 16, 2000
A phase II evaluation of bexarotene (Targretin) capsules in patients with metastatic melanomaA Y Bedikian, C Plager, N Papadopoulos, et al.
Cancer Research|November 1, 1978
Disposition and metabolism of 1-(tetrahydro-2-furanyl)-5-fluorouracil (ftorafur) in humansJ A Benvenuto, K Lu, S W Hall, et al.
American Journal of Clinical Oncology|April 1, 1995
Efficacy of liposomal muramyl tripeptide (CGP 19835A) in the treatment of relapsed osteosarcomaE S Kleinerman, J B Gano, D A Johnston, et al.
Journal of Neurosurgery|May 1, 1978
Meningeal melanocytoma with invasion of the thoracic spinal cord. Case reportJ M Steinberg, J J Gillespie, B MacKay, et al.
Cancer Treatment Reports|May 1, 1979
Clinical studies with rubidazoneR S Benjamin, M J Keating, K D Swenerton, et al.
Cancer|December 1, 1979
Adriamycin, BCNU, ftorafur chemotherapy of pancreatic and biliary tract cancerS W Hall, R S Benjamin, W K Murphy, et al.
Investigational New Drugs|April 1, 1988
Phase II study of AMSA alone and in combination with DTIC in patients with metastatic melanomaA Polyzos, S S Legha, A M Burgess, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1982
Bleomycin clinical pharmacology by radioimmunoassayS W Hall, J E Strong, A Broughton, et al.
Pageof 26

Showing results (81-90 of 258) with videos related to

Sort By:
Pageof 26
Clinical Oncology|June 1, 1979
Regression of regionally advanced melanoma after arterial infusion with cis-platinum and actinomycin-DJ D Pritchard, G M Mavligit, S Wallace, et al.
Cancer|November 1, 1976
A comparison of cyclophosphamide, vincristine, and prednisone (COP) with nitrogen mustard, vincristine, procarbazine, and prednisone (MOPP) in the treatment of nodular, poorly differentiated, lymphocytic lymphomaR S Benjamin, P H Wiernik, M J O'Connell, et al.
Oncology Reports|June 16, 2000
A phase II evaluation of bexarotene (Targretin) capsules in patients with metastatic melanomaA Y Bedikian, C Plager, N Papadopoulos, et al.
Cancer Research|November 1, 1978
Disposition and metabolism of 1-(tetrahydro-2-furanyl)-5-fluorouracil (ftorafur) in humansJ A Benvenuto, K Lu, S W Hall, et al.
American Journal of Clinical Oncology|April 1, 1995
Efficacy of liposomal muramyl tripeptide (CGP 19835A) in the treatment of relapsed osteosarcomaE S Kleinerman, J B Gano, D A Johnston, et al.
Journal of Neurosurgery|May 1, 1978
Meningeal melanocytoma with invasion of the thoracic spinal cord. Case reportJ M Steinberg, J J Gillespie, B MacKay, et al.
Cancer Treatment Reports|May 1, 1979
Clinical studies with rubidazoneR S Benjamin, M J Keating, K D Swenerton, et al.
Cancer|December 1, 1979
Adriamycin, BCNU, ftorafur chemotherapy of pancreatic and biliary tract cancerS W Hall, R S Benjamin, W K Murphy, et al.
Investigational New Drugs|April 1, 1988
Phase II study of AMSA alone and in combination with DTIC in patients with metastatic melanomaA Polyzos, S S Legha, A M Burgess, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1982
Bleomycin clinical pharmacology by radioimmunoassayS W Hall, J E Strong, A Broughton, et al.
Pageof 26